Omada Health's CEO, Sean Duffy, went on a leave of absence from Harvard’s MD/MBA program so that he could build a digital health company to help people with prediabetes. In the world of medical students, admission to Harvard is a grand prize, and we have to take into consideration that the Harvard MBA program comes studded with precious gems!
It turns out that Sean made the right decision for himself and for healthcare. His company just closed a $23 million Series B round led by Andreeson Horowitz with participation by Kaiser Permanente Ventures. More importantly, Omada’s first product, Prevent, is fully operational and helping people with pre-diabetes lose weight and make lifestyle changes that should help them slow or avoid progression to full-blown diabetes.
Instead of helping patients one at a time, Sean, through Omada, is helping populations of individuals with this condition...
To read the full article, click here.